Reducing the Risk During Cell and Gene Therapy Development and Manufacturing

MilliporeSigma shares insights for navigating within the novel and complex regulatory environment facing cell and gene therapies, mitigating risks posed by raw materials, and implementing proper risk assessments during manufacturing.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: